Stay updated on Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole
Sign up to get notified when there's something new on the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page.

Latest updates to the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations section updated: Quebec added as a new site and the previous Quebec location removed. The HHS Vulnerability Disclosure footer link was removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page shows Revision: v3.3.2, replacing v3.2.0, with no detectable changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedNotice about government funding lapse and operating-status information was removed; this does not affect core study data or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedNo significant changes observed in the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference2%

- Check95 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Camlipixant PK with Rifampin and Rabeprazole page.